home / stock / rvph / rvph quote
Last: | $1.17 |
---|---|
Change Percent: | 0.93% |
Open: | $1.06 |
Close: | $1.17 |
High: | $1.22 |
Low: | $1.06 |
Volume: | 370,083 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.17 | $1.06 | $1.17 | $1.22 | $1.06 | 370,083 | 07-05-2024 |
$1.07 | $1.075 | $1.07 | $1.09 | $1.05 | 140,011 | 07-04-2024 |
$1.07 | $1.075 | $1.07 | $1.09 | $1.05 | 140,011 | 07-03-2024 |
$1.08 | $1.2 | $1.08 | $1.2 | $1.07 | 206,386 | 07-02-2024 |
$1.19 | $1.27 | $1.19 | $1.28 | $1.19 | 74,994 | 07-01-2024 |
$1.28 | $1.28 | $1.28 | $1.3 | $1.26 | 67,201 | 06-28-2024 |
$1.28 | $1.25 | $1.28 | $1.29 | $1.23 | 118,022 | 06-27-2024 |
$1.25 | $1.26 | $1.25 | $1.28 | $1.23 | 63,012 | 06-26-2024 |
$1.26 | $1.29 | $1.26 | $1.3 | $1.26 | 86,743 | 06-25-2024 |
$1.28 | $1.26 | $1.28 | $1.31 | $1.24 | 129,086 | 06-24-2024 |
$1.25 | $1.36 | $1.25 | $1.36 | $1.25 | 136,391 | 06-21-2024 |
$1.35 | $1.36 | $1.35 | $1.38 | $1.31 | 120,218 | 06-20-2024 |
$1.37 | $1.45 | $1.37 | $1.45 | $1.36 | 97,528 | 06-19-2024 |
$1.37 | $1.45 | $1.37 | $1.45 | $1.36 | 97,528 | 06-18-2024 |
$1.45 | $1.47 | $1.45 | $1.47 | $1.43 | 50,814 | 06-17-2024 |
$1.46 | $1.5 | $1.46 | $1.5 | $1.44 | 124,837 | 06-14-2024 |
$1.5 | $1.5 | $1.5 | $1.53 | $1.453 | 119,237 | 06-13-2024 |
$1.51 | $1.49 | $1.51 | $1.54 | $1.48 | 338,892 | 06-12-2024 |
$1.49 | $1.43 | $1.49 | $1.49 | $1.43 | 117,745 | 06-11-2024 |
$1.45 | $1.42 | $1.45 | $1.48 | $1.4 | 524,316 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Reviva Pharmaceuticals Holdings Inc. Company Name:
RVPH Stock Symbol:
NASDAQ Market:
Reviva Pharmaceuticals Holdings Inc. Website:
2024-06-11 08:15:03 ET H.C. Wainwright analyst issues BUY recommendation for RVPH on June 11, 2024 06:40AM ET. The previous analyst recommendation was Buy. RVPH was trading at $1.45 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...
CUPERTINO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous ...
CUPERTINO, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous ...